CED Life Science presenter profile: BetaBlue

Editor’s note: WRAL TechWire and the Council for Entrepreneurial development are partnering to present a series of profiles and Q&As featuring companies startups and emerging companies participating in the CED’s annual Life Science conference coming up Feb. 28-March 1 in Raleigh. The latest profile is BetaBlue, which is based in Graham, N.C. and targets schizophrenia.

Ontario children and youth with ADHD often prescribed antipsychotics, study finds

A study by the Institute for Clinical Evaluative Sciences found almost 12 per cent of kids and youth with attention deficit hyperactivity disorder, or ADHD, were prescribed antipsychotics like Risperdal, Zyprexa and Seroquel. One in 20 Ontario children and youth have attention deficit hyperactivity disorder and many are prescribed antipsychotic drugs, despite having no other mental health diagnoses, researchers have found.

Schizophrenia US Therapeutic and Drug Pipeline Review H2

PUNE, INDIA, January 17, 2017 / EINPresswire.com / — GET SAMPLE REPORT @ Summary Schizophrenia is a heterogeneous behavioral and cognitive syndrome involving chronic or recurrent psychosis. The disorder is characterized by several symptom domains including positive symptoms , negative symptoms , and cognitive deficits .